<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47">
 <label>47.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Folegatti</surname>
    <given-names>PM</given-names>
   </name>
   <name>
    <surname>Ewer</surname>
    <given-names>KJ</given-names>
   </name>
   <name>
    <surname>Aley</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Angus</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Becker</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Belij-Rammerstorfer</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial</article-title>. 
  <source>Lancet.</source> (
  <year>2020</year>) 
  <volume>396</volume>:
  <fpage>467</fpage>â€“
  <lpage>78</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)31604-4</pub-id>
  <?supplied-pmid 32702298?>
  <pub-id pub-id-type="pmid">32702298</pub-id>
 </mixed-citation>
</ref>
